長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4521】科研製薬

【4521】科研製薬
製薬。関節機能改善剤。
類似企業：


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/08 Q2予 88,500 → 0.0% +17.8% 20,800 → 0.0% +181.1% 21,200 → 0.0% +171.8% 14,200 → 0.0% +153.6%
2025.03 2024/08/07 Q1予 88,500 ↑ +17.8% +17.8% 20,800 ↑ +181.1% +181.1% 21,200 ↑ +171.8% +171.8% 14,200 ↑ +153.6% +153.6%
2025.03 2024/05/14 当初予 75,100 - - - 7,400 - - - 7,800 - - - 5,600 - - -
2024.03 2024/05/14 実 72,044 ↓ -1.4% -1.4% 9,513 ↑ +25.2% +25.2% 9,951 ↑ +24.4% +24.4% 8,025 ↑ +19.8% +19.8%
2024.03 2024/02/06 Q3予 73,100 → 0.0% 0.0% 7,600 → 0.0% 0.0% 8,000 → 0.0% 0.0% 6,700 → 0.0% 0.0%
2024.03 2023/11/08 Q2予 73,100 → 0.0% 0.0% 7,600 → 0.0% 0.0% 8,000 → 0.0% 0.0% 6,700 → 0.0% 0.0%
2024.03 2023/08/04 Q1予 73,100 → 0.0% 0.0% 7,600 → 0.0% 0.0% 8,000 → 0.0% 0.0% 6,700 → 0.0% 0.0%
2024.03 2023/05/10 当初予 73,100 - - - 7,600 - - - 8,000 - - - 6,700 - - -
2023.03 2023/05/10 実 72,984 ↓ -0.7% -4.5% 7,998 ↑ +6.6% -46.7% 8,727 ↑ +7.7% -43.7% 5,440 ↓ -10.8% -54.7%
2023.03 2023/02/03 Q3予 73,500 ↓ -3.8% -3.8% 7,500 ↓ -50.0% -50.0% 8,100 ↓ -47.7% -47.7% 6,100 ↓ -49.2% -49.2%
2023.03 2022/11/08 Q2予 76,400 → 0.0% 0.0% 15,000 → 0.0% 0.0% 15,500 → 0.0% 0.0% 12,000 → 0.0% 0.0%
2023.03 2022/08/03 Q1予 76,400 → 0.0% 0.0% 15,000 → 0.0% 0.0% 15,500 → 0.0% 0.0% 12,000 → 0.0% 0.0%
2023.03 2022/05/11 当初予 76,400 - - - 15,000 - - - 15,500 - - - 12,000 - - -
2022.03 2022/05/11 実 76,034 ↑ +0.0% -4.0% 17,064 ↑ +3.4% -9.2% 17,542 ↑ +3.2% -8.6% 9,549 ↑ +3.8% -31.8%
2022.03 2022/03/29 修正予 76,000 ↓ -4.0% -4.0% 16,500 ↓ -12.2% -12.2% 17,000 ↓ -11.5% -11.5% 9,200 ↓ -34.3% -34.3%
2022.03 2022/02/03 Q3予 79,200 → 0.0% 0.0% 18,800 → 0.0% 0.0% 19,200 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2022.03 2021/11/04 Q2予 79,200 → 0.0% 0.0% 18,800 → 0.0% 0.0% 19,200 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2022.03 2021/08/03 Q1予 79,200 → 0.0% 0.0% 18,800 → 0.0% 0.0% 19,200 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2022.03 2021/05/07 当初予 79,200 - - - 18,800 - - - 19,200 - - - 14,000 - - -
2021.03 2021/05/07 実 74,979 ↓ -2.9% -9.6% 17,788 ↓ -1.7% -14.5% 18,222 ↓ -1.5% -14.0% 13,405 ↑ +0.0% -10.6%
2021.03 2021/02/03 Q3予 77,200 → 0.0% -6.9% 18,100 → 0.0% -13.0% 18,500 → 0.0% -12.7% 13,400 → 0.0% -10.7%
2021.03 2020/11/05 Q2予 77,200 → 0.0% -6.9% 18,100 → 0.0% -13.0% 18,500 → 0.0% -12.7% 13,400 → 0.0% -10.7%
2021.03 2020/10/27 修正予 77,200 ↓ -6.9% -6.9% 18,100 ↓ -13.0% -13.0% 18,500 ↓ -12.7% -12.7% 13,400 ↓ -10.7% -10.7%
2021.03 2020/08/03 Q1予 82,900 - - - 20,800 - - - 21,200 - - - 15,000 - - -
2020.03 2020/03/27 修正予 89,000 ↓ -4.2% -4.2% 26,000 ↑ +16.6% +16.6% 26,400 ↑ +16.3% +16.3% 18,600 ↑ +15.5% +15.5%
2020.03 2020/02/03 Q3予 92,900 → 0.0% 0.0% 22,300 → 0.0% 0.0% 22,700 → 0.0% 0.0% 16,100 → 0.0% 0.0%
2020.03 2019/11/06 Q2予 92,900 → 0.0% 0.0% 22,300 → 0.0% 0.0% 22,700 → 0.0% 0.0% 16,100 → 0.0% 0.0%
2020.03 2019/08/01 Q1予 92,900 → 0.0% 0.0% 22,300 → 0.0% 0.0% 22,700 → 0.0% 0.0% 16,100 → 0.0% 0.0%
2020.03 2019/05/09 当初予 92,900 - - - 22,300 - - - 22,700 - - - 16,100 - - -
2019.03 2019/05/09 実 94,165 ↓ -0.7% -0.7% 24,592 ↑ +9.3% +9.3% 24,972 ↑ +9.5% +9.5% 17,775 ↑ +8.4% +8.4%
2019.03 2019/02/01 Q3予 94,800 → 0.0% 0.0% 22,500 → 0.0% 0.0% 22,800 → 0.0% 0.0% 16,400 → 0.0% 0.0%
2019.03 2018/11/06 Q2予 94,800 → 0.0% 0.0% 22,500 → 0.0% 0.0% 22,800 → 0.0% 0.0% 16,400 → 0.0% 0.0%
2019.03 2018/08/01 Q1予 94,800 - - - 22,500 - - - 22,800 - - - 16,400 - - -
2018.03 2018/02/01 Q3予 101,700 → 0.0% 0.0% 26,800 → 0.0% 0.0% 27,000 → 0.0% 0.0% 19,100 → 0.0% 0.0%
2018.03 2017/11/06 Q2予 101,700 → 0.0% 0.0% 26,800 → 0.0% 0.0% 27,000 → 0.0% 0.0% 19,100 → 0.0% 0.0%
2018.03 2017/08/01 Q1予 101,700 → 0.0% 0.0% 26,800 → 0.0% 0.0% 27,000 → 0.0% 0.0% 19,100 → 0.0% 0.0%
2018.03 2017/05/10 当初予 101,700 - - - 26,800 - - - 27,000 - - - 19,100 - - -
2017.03 2017/05/10 実 101,479 ↑ +0.2% -4.4% 30,707 ↑ +0.3% +6.3% 30,981 ↑ +0.3% +6.5% 22,017 ↑ +1.0% +5.9%
2017.03 2017/03/28 修正予 101,300 ↓ -4.5% -4.5% 30,600 ↑ +5.9% +5.9% 30,900 ↑ +6.2% +6.2% 21,800 ↑ +4.8% +4.8%
2017.03 2017/02/06 Q3予 106,100 → 0.0% 0.0% 28,900 → 0.0% 0.0% 29,100 → 0.0% 0.0% 20,800 → 0.0% 0.0%
2017.03 2016/11/07 Q2予 106,100 → 0.0% 0.0% 28,900 → 0.0% 0.0% 29,100 → 0.0% 0.0% 20,800 → 0.0% 0.0%
2017.03 2016/08/03 Q1予 106,100 → 0.0% 0.0% 28,900 → 0.0% 0.0% 29,100 → 0.0% 0.0% 20,800 → 0.0% 0.0%
2017.03 2016/05/12 当初予 106,100 - - - 28,900 - - - 29,100 - - - 20,800 - - -
2016.03 2016/05/12 実 109,730 ↑ +1.7% +11.4% 35,146 ↑ +9.1% +67.4% 35,365 ↑ +9.2% +67.6% 21,143 ↑ +10.1% +51.0%
2016.03 2016/02/05 Q3予 107,900 → 0.0% +9.5% 32,200 → 0.0% +53.3% 32,400 → 0.0% +53.6% 19,200 → 0.0% +37.1%
2016.03 2015/11/06 Q2予 107,900 → 0.0% +9.5% 32,200 → 0.0% +53.3% 32,400 → 0.0% +53.6% 19,200 → 0.0% +37.1%
2016.03 2015/10/27 修正予 107,900 ↑ +9.5% +9.5% 32,200 ↑ +53.3% +53.3% 32,400 ↑ +53.6% +53.6% 19,200 ↑ +37.1% +37.1%
2016.03 2015/08/05 Q1予 98,500 → 0.0% 0.0% 21,000 → 0.0% 0.0% 21,100 → 0.0% 0.0% 14,000 → 0.0% 0.0%
2016.03 2015/05/12 当初予 98,500 - - - 21,000 - - - 21,100 - - - 14,000 - - -
2015.03 2015/05/12 実 93,889 ↓ -0.0% +2.7% 20,631 ↑ +0.2% +22.8% 20,394 ↑ +0.5% +24.4% 12,122 ↑ +2.7% +13.3%
2015.03 2015/03/26 修正予 93,900 ↑ +2.7% +2.7% 20,600 ↑ +22.6% +22.6% 20,300 ↑ +23.8% +23.8% 11,800 ↑ +10.3% +10.3%
2015.03 2015/02/05 Q3予 91,400 → 0.0% 0.0% 16,800 → 0.0% 0.0% 16,400 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2015.03 2014/11/06 Q2予 91,400 → 0.0% 0.0% 16,800 → 0.0% 0.0% 16,400 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2015.03 2014/08/05 Q1予 91,400 → 0.0% 0.0% 16,800 → 0.0% 0.0% 16,400 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2015.03 2014/05/12 当初予 91,400 - - - 16,800 - - - 16,400 - - - 10,700 - - -
2014.03 2014/05/12 実 88,946 - - - 15,872 - - - 15,521 - - - 9,735 - - -
シェア ツイート
ページトップへ戻る